Skip to content

Clinical trials

Retinitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20111
20131
20181
20191
20212
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Active, not recruiting3
Recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)15
Hoffmann-La Roche6
Astra USA4
Roche Global Development3
Gilead Sciences2
Nanoscope Therapeutics Inc.2
National Eye Institute (NEI)2
American National Red Cross1
Chiron Corporation1
Daniel Benjamin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis47
Acquired Immunodeficiency Syndrome36
Cytomegalovirus Retinitis36
HIV Infections35
Cytomegalovirus Infections31
Multiple Acyl Coenzyme A Dehydrogenase Deficiency25
AIDS-Related Opportunistic Infections16
Retinitis Pigmentosa6
Eye Diseases4
Eye Diseases, Hereditary4

Trials

Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.